Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

NOVOCURE INC.

Filed by NOVOCURE INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 16, 2025
Income
Not reported
Expenses
$110,000.00
Registrant
NOVOCURE INC.
Filing UUID
7c73f894-c370-4d9d-b7c0-049865350b0c
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

General Medicare Issues. H.R.1691/S.5349 - Ensuring Patient Access to Critical Breakthrough Products Act of 2024.

Literal federal measure citations: H.R.1691, S.5349

VET · Veterans

Veterans Affairs / Veterans Health Administration (VHA) issues.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.